Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker Guided Treatment in Gynaecological Cancer
NCT02543710Phase 4Recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, open-label trial of paclitaxel in endometrial cancer (EC) and ovarian cancer (2 arms), sponsored by Haukeland University Hospital. Primary endpoints: Number of recurrences after primary treatment at 5 years and Stathmin levels. Started Oct 2015; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
endometrial cancer (EC)ovarian cancer
Beyond the preview
Go deeper on NCT02543710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543710.